| Debra Elizabeth Rhiver, APRN, BC | |
|
2625 Salem Xing, Tucker, GA 30084-2364 | |
| (678) 248-4346 | |
| Not Available |
| Full Name | Debra Elizabeth Rhiver |
|---|---|
| Gender | Female |
| Speciality | Certified Clinical Nurse Specialist (cns) |
| Experience | 26 Years |
| Location | 2625 Salem Xing, Tucker, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861603912 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Grady Memorial Hospital Corporation | 7517032998 | 252 |
News Archive
DICOM Grid, the #1 medical image exchange vendor, announced today that it was recognized as the winner of the 2015 SIIA CODiE Award for Best Health and Medical Information Solution. Winners were announced today during a luncheon at the Mandarin Oriental in Washington, D.C.
Researchers from Mount Sinai School of Medicine have developed a new computational method that will make it easier for scientists to identify and prioritize genes, drug targets, and strategies for repositioning drugs that are already on the market. By mining large datasets more simply and efficiently, researchers will be able to better understand gene-gene, protein-protein, and drug/side-effect interactions. The new algorithm will also help scientists identify fellow researchers with whom they can collaborate.
The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday released Issue 4 of its newsletter, the "Global Fund News Flash." The issue features a commentary by Mireille Guigaz, a Global Fund Board member representing France, on the Global Fund's work in Madagascar, and a piece examining "a Board decision last November that 55 percent of all funding for grant renewals should go to low-income countries," among other stories.
Castle Biosciences, Inc., the skin cancer diagnostics company providing molecular diagnostics to improve cancer management decisions, today announced the presentation of data highlighting how the accuracy of the DecisionDx-Melanoma gene expression profile (GEP) test in patients with Stage II and IIIA melanoma can improve adjuvant clinical trial design at the 2018 Society for Melanoma Research International Congress held in Manchester, England from October 24-27.
› Verified 8 days ago
| Entity Name | Grady Memorial Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114243813 PECOS PAC ID: 7517032998 Enrollment ID: O20100723000311 |
News Archive
DICOM Grid, the #1 medical image exchange vendor, announced today that it was recognized as the winner of the 2015 SIIA CODiE Award for Best Health and Medical Information Solution. Winners were announced today during a luncheon at the Mandarin Oriental in Washington, D.C.
Researchers from Mount Sinai School of Medicine have developed a new computational method that will make it easier for scientists to identify and prioritize genes, drug targets, and strategies for repositioning drugs that are already on the market. By mining large datasets more simply and efficiently, researchers will be able to better understand gene-gene, protein-protein, and drug/side-effect interactions. The new algorithm will also help scientists identify fellow researchers with whom they can collaborate.
The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday released Issue 4 of its newsletter, the "Global Fund News Flash." The issue features a commentary by Mireille Guigaz, a Global Fund Board member representing France, on the Global Fund's work in Madagascar, and a piece examining "a Board decision last November that 55 percent of all funding for grant renewals should go to low-income countries," among other stories.
Castle Biosciences, Inc., the skin cancer diagnostics company providing molecular diagnostics to improve cancer management decisions, today announced the presentation of data highlighting how the accuracy of the DecisionDx-Melanoma gene expression profile (GEP) test in patients with Stage II and IIIA melanoma can improve adjuvant clinical trial design at the 2018 Society for Melanoma Research International Congress held in Manchester, England from October 24-27.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Debra Elizabeth Rhiver, APRN, BC 2625 Salem Xing, Tucker, GA 30084-2364 Ph: (404) 354-4469 | Debra Elizabeth Rhiver, APRN, BC 2625 Salem Xing, Tucker, GA 30084-2364 Ph: (678) 248-4346 |
News Archive
DICOM Grid, the #1 medical image exchange vendor, announced today that it was recognized as the winner of the 2015 SIIA CODiE Award for Best Health and Medical Information Solution. Winners were announced today during a luncheon at the Mandarin Oriental in Washington, D.C.
Researchers from Mount Sinai School of Medicine have developed a new computational method that will make it easier for scientists to identify and prioritize genes, drug targets, and strategies for repositioning drugs that are already on the market. By mining large datasets more simply and efficiently, researchers will be able to better understand gene-gene, protein-protein, and drug/side-effect interactions. The new algorithm will also help scientists identify fellow researchers with whom they can collaborate.
The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday released Issue 4 of its newsletter, the "Global Fund News Flash." The issue features a commentary by Mireille Guigaz, a Global Fund Board member representing France, on the Global Fund's work in Madagascar, and a piece examining "a Board decision last November that 55 percent of all funding for grant renewals should go to low-income countries," among other stories.
Castle Biosciences, Inc., the skin cancer diagnostics company providing molecular diagnostics to improve cancer management decisions, today announced the presentation of data highlighting how the accuracy of the DecisionDx-Melanoma gene expression profile (GEP) test in patients with Stage II and IIIA melanoma can improve adjuvant clinical trial design at the 2018 Society for Melanoma Research International Congress held in Manchester, England from October 24-27.
› Verified 8 days ago
Ms. Dorothy Delisfort-crisostomo, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4228 1st Ave Ste 1, Tucker, GA 30084 Phone: 833-583-4778 Fax: 833-583-4779 | |
Katrina R Bader, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 200 Cres Ctr Pkwy, Department Of Research, Tucker, GA 30084 Phone: 770-496-3770 | |
Mrs. Melanie Noelle Mcmillan, MSN, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2260 Northlake Pkwy Ste 211, Tucker, GA 30084 Phone: 770-491-1344 | |
Solina Jinju Chiang, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1468 Montreal Rd, Tucker, GA 30084 Phone: 770-638-1400 | |
Harriett Laschell Allen, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1468 Montreal Rd, Tucker, GA 30084 Phone: 770-638-1400 | |
Cassandra A Westbrook, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4088 Brookside Manor Dr, Tucker, GA 30084 Phone: 770-686-3428 Fax: 770-686-3428 | |
Dr. Turnisha Monique Carter, PMHNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3469 Lawrenceville Hwy Ste 103, Tucker, GA 30084 Phone: 770-939-6480 Fax: 770-638-1961 |